Michal J Besser

9PUBLICATIONS
46CO-AUTHORS
Gene and molecular therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 21, 2025
Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatment.

Simon Turcotte, Marco Donia, Brian Gastman

|Nov 07, 2024
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction.

David W Vredevoogd, Georgi Apriamashvili, Pierre L Levy

|Apr 19, 2023
MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2.

Ettai Markovits, Ortal Harush, Erez N Baruch

|Dec 21, 2022
Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes.

Elad Jacoby, Omer Bar-Yosef, Noah Gruber

|Jun 22, 2022
Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells.

Naama Margolis, Hanna Moalem, Tomer Meirson

|May 15, 2021
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy.

Abraham Nissani, Shaked Lev-Ari, Tomer Meirson

Pageof 2